Are you Dr. Khemka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
14200 W Celebrate Life Way
Goodyear, AZ 85338Phone+1 623-207-3000
Summary
- Dr. Vivek Khemka, MD is an oncologist in Goodyear, Arizona. He is currently licensed to practice medicine in Arizona, California, and Washington.
Education & Training
Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
Zucker School of Medicine at Hofstra/NorthwellFellowship, Geriatric Medicine (Internal Medicine), 2003 - 2004
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2003
Wyckoff Heights Medical CenterInternship, Internal Medicine, 2000 - 2001
Sri Ramachandra Medical CollegeClass of 1993
Certifications & Licensure
AZ State Medical License 2008 - 2026
CA State Medical License 2011 - 2026
NY State Medical License 2003 - 2026
NJ State Medical License 2005 - 2025
WA State Medical License 2011 - 2025- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Geriatric Medicine
- National Board of Physicians and Surgeons Hospice and Palliative Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Publications & Presentations
PubMed
- 101 citationsA phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)Glen J. Weiss, Jordan Waypa, Lisa Blaydorn, Jessica Coats, Kayla McGahey
British Journal of Cancer. 2017-06-27 - 140 citationsPhase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J. Weiss, Lisa Blaydorn, Julia Beck, Kirsten Bornemann-Kolatzki, Howard B. Urnovitz
Investigational New Drugs. 2018-02-01 - 110 citationsTumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to ImmunotherapyGlen J. Weiss, Julia Beck, Donald P Braun, Kristen Bornemann-Kolatzki, Heather Barilla
Clinical Cancer Research. 2017-09-01
Press Mentions
CTCA at Western Regional Medical Center Advances Combination Immunotherapy Clinical TrialJanuary 8th, 2016
Clinical Trial Using Immunotherapy Drug Combinations to Treat Lung Cancer Appears SafeSeptember 9th, 2015
CTCA Initiates New Clinical Study of Immunotherapy Combined with ChemotherapyJuly 1st, 2015
Professional Memberships
- Member
- Member
